Number of Participants With Splenectomy During 52-Week Treatment Period 52 weeks [clinicaltrials_resource:3ddc37675542ce2a30140278287b5eac]
Occurrence of a splenectomy. Participants who discontinued study during the treatment period prior to reporting a splenectomy were considered as having had a splenectomy.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Number of Participants With Splenectomy During 52-Week Treatment Period 52 weeks [clinicaltrials_resource:3ddc37675542ce2a30140278287b5eac]
Occurrence of a splenectomy. Participants who discontinued study during the treatment period prior to reporting a splenectomy were considered as having had a splenectomy.
Bio2RDF identifier
3ddc37675542ce2a30140278287b5eac
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3ddc37675542ce2a30140278287b5eac
measure [clinicaltrials_vocabulary:measure]
Number of Participants With Splenectomy During 52-Week Treatment Period
time frame [clinicaltrials_vocabulary:time-frame]
description
Occurrence of a splenectomy. P ...... d as having had a splenectomy.
identifier
clinicaltrials_resource:3ddc37675542ce2a30140278287b5eac
title
Number of Participants With Splenectomy During 52-Week Treatment Period 52 weeks
@en
type
label
Number of Participants With Sp ...... c37675542ce2a30140278287b5eac]
@en